Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma.

Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34485283

about

Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers Screening and surveillance for hepatocellular carcinoma: perspective of a new era?Upregulation of microRNA-143 reverses drug resistance in human breast cancer cells via inhibition of cytokine-induced apoptosis inhibitor 1 Identification of valid reference genes for microRNA expression studies in a hepatitis B virus replicating liver cell line.MicroRNA panels as disease biomarkers distinguishing hepatitis B virus infection caused hepatitis and liver cirrhosis.Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China.miR-215 promotes malignant progression of gastric cancer by targeting RUNX1 Surveillance and Diagnosis of Hepatocellular Carcinoma.Reduced miR-215 expression predicts poor prognosis in patients with acute myeloid leukemia Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison.Role of microRNAs in inflammation-associated liver cancer MicroRNA-215 targets NOB1 and inhibits growth and invasion of epithelial ovarian cancer.A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis Systematic Review and Meta-Analysis: Circulating miRNAs for Diagnosis of Hepatocellular Carcinoma.miRNA for diagnosis and clinical implications of human hepatocellular carcinoma.Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?Identification of the novel 3' UTR sequences of human IL-21 mRNA as potential targets of miRNAs.Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.The novel long intergenic noncoding RNA UCC promotes colorectal cancer progression by sponging miR-143.Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.Circulating microRNAs for early detection of hepatitis B-related hepatocellular carcinoma.Diagnostic and prognostic significance of serum miR-24-3p in HBV-related hepatocellular carcinoma.Circulating miRNAs as novel diagnostic biomarkers in hepatocellular carcinoma detection: a meta-analysis based on 24 articles.Identification and Evaluation of Novel MicroRNA Biomarkers in Plasma and Feces Associated with Drug-induced Intestinal Toxicity.Evaluation of Mir-224, Mir-215 and Mir-143 as Serum Biomarkers for HCV Associated Hepatocellular Carcinoma Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.Circulating serum miRNAs as potential biomarkers for nephroblastoma.Serum microRNA-145 as a novel biomarker in human ovarian cancer.miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5.Association of plasma microRNA expression with age, genetic background and functional traits in dairy cattle

P2860

Q26741204-D4C8E127-72E0-4C97-976C-7A97EC67537C Q28080153-180361EB-C699-429C-B43C-29CF70DE673E Q30244651-623CA276-5E6D-408C-B0EC-81729CDD2A7F Q33750756-C4238B10-5658-4376-9808-470151B962AC Q35902096-BB75DDBE-F96C-4E1B-BBAB-D882FDFBA560 Q36146616-8A4925C0-6630-4DD7-A1D6-DB6452F190D6 Q36150993-AF1E159E-C36E-44E8-9B1B-77919CBC3502 Q36782595-E36014FE-F46E-4C82-A841-8567FDAE0B5E Q36812480-E5AEEAC9-38C3-476A-9CD4-2E33C8DCFBF5 Q36949308-6846ADE4-2638-4201-B5E0-C6E422060691 Q37472263-FA27E2CE-CA22-40DE-BBC5-760B18FCF2C6 Q37596666-E314C6C0-8F89-4FDD-B31E-CA2E6101DBEF Q37685240-E93F20D8-14DC-4CA9-89A9-62C2CE39547B Q37702806-7D6271C9-E6E4-48A1-9842-B8D3672DEEFC Q38387466-4418AD37-C2A9-4F8A-9D0A-8C401F9EED80 Q38568853-FF59C3CB-FE33-4313-BAE9-304CA9024696 Q38588428-FF83EEA9-8E6B-4B7D-B4AD-21FFE7BA5F0A Q39197775-B11FA170-4D3C-453F-8114-3B05B2CEFD9E Q40086494-C8D9F4E1-C922-4C59-AD2A-8EE7AB9324EB Q40392279-77322CFC-4744-4AFB-868D-3B782F9C950B Q40836505-A71D5D22-5773-419C-8280-100D94A7DF42 Q41082597-F52CBC9C-3DB3-4574-B4A6-7774240112A2 Q41505555-199945AD-D364-40E2-B29D-D42CB287ED76 Q41822877-3E28EEC7-B258-4772-87A6-F85ED2568E84 Q42199617-FC043894-85B4-49E0-B99E-B5E9C19DF5F9 Q42371643-4DB06745-0C88-4688-B5DE-5C581E7C9214 Q46155121-73517FFB-5141-4544-BCF6-E1DEA5383D9F Q49217371-8ED32FE7-BB9A-4D26-B8C4-BD6839EE734B Q53531177-6F348136-7917-45DD-8D97-4E3FB7F320A0 Q53573234-F9C1A71F-F03E-45A5-916C-18B0DF972CD2 Q53602008-D0601781-A8D2-4971-8CF3-E655DCAB9C4D Q54231260-A143B7AA-537B-456B-A2FE-048E5C429958 Q58699460-775D829D-B73E-4F47-9D37-3839883DACB7

P2860

Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34485283

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Serum microRNA 143 and microRN ...... and hepatocellular carcinoma.

@ast

Serum microRNA 143 and microRN ...... and hepatocellular carcinoma.

@en

Serum microRNA 143 and microRN ...... and hepatocellular carcinoma.

@nl

type

label

Serum microRNA 143 and microRN ...... and hepatocellular carcinoma.

@ast

Serum microRNA 143 and microRN ...... and hepatocellular carcinoma.

@en

Serum microRNA 143 and microRN ...... and hepatocellular carcinoma.

@nl

prefLabel

Serum microRNA 143 and microRN ...... and hepatocellular carcinoma.

@ast

Serum microRNA 143 and microRN ...... and hepatocellular carcinoma.

@en

Serum microRNA 143 and microRN ...... and hepatocellular carcinoma.

@nl

P1433

Q34485283-D94CD744-2579-4E73-A829-831809F1B667

P1476

Q34485283-BA1A96FB-DC0C-4C22-8A8E-C8F9CE5DAC81

P2093

Q34485283-25F35ED5-7A32-4D2E-B4E3-2FD7AB5AFEF2

Q34485283-7835239A-EB9A-41C1-91AB-0AC9B5DF1B26

Q34485283-83172A00-136D-48EB-8D3B-6DFDFDF12189

Q34485283-AF7E0B33-D114-4C99-B739-6C27B56A9B53

Q34485283-B990BD0D-C865-460A-A477-9ECE079FB26E

Q34485283-BCC0B426-EB7E-4966-AAE5-8F42E23F341C

Q34485283-CBBE3168-DFCD-4B54-8C54-DF106AF229ED

P2860

Q34485283-0098BB6F-EDA6-480F-8711-6FA520E4FFF6

Q34485283-01E1A7B1-2783-403F-8821-83412A07E6EF

Q34485283-162D5D35-9469-410E-BA21-B04C52CCCB98

Q34485283-169747B9-9509-4DA1-BB98-A9A37DECB467

Q34485283-2072DCEE-94D9-461A-AA9F-BF69A96D13E7

Q34485283-26A437ED-0CB8-4795-A0D7-F32BA575D39F

Q34485283-38AB318E-601C-46DF-99F4-9205DCF75DF4

Q34485283-418B3BC7-215A-41E1-8227-985FC444912B

Q34485283-4D1D7C02-0EF4-4A5C-91B9-C90B78DF78F3

Q34485283-4D7F1F26-6AAF-4CF3-839A-57823B946926

P2888

Q34485283-14794B0D-FE85-4FB3-A339-F30A3FD78C7B

P304

Q34485283-D93797E7-4A8E-4B49-A84D-3AFA109EA177

P31

Q34485283-8CCE3FC8-9693-4963-B0F6-08416B492EC9

P356

Q34485283-C1F0B132-2708-4F4D-B55E-9681AC62C200

P478

Q34485283-22BC2E93-3EDE-452A-BB6D-095A2CC0B4F5

P577

Q34485283-F12220E8-8D38-4287-9F30-335003649C57

P5875

Q34485283-8B32B106-F4DB-4C4D-ACC5-851CDBEC6AA1

P6179

Q34485283-ED32457D-FDDD-4E57-8730-5722D0019C60

P698

Q34485283-A66FCAA0-486B-40B2-A4E8-D89F85893FCC

P921

Q34485283-49EDB69B-3C22-41D3-B349-BF1AF81F28D3

Q34485283-85CE047D-DB87-472F-91E9-45DAE2D177C1

P932

Q34485283-9F0A6E31-2CFE-4B5B-AA36-672CFBDA0323

P356

1746-1596-9-135

P1433

Diagnostic Pathology

P1476

Serum microRNA 143 and microRN ...... and hepatocellular carcinoma.

@en

P2093

Hua Meng

http://www.w3.org/2001/XMLSchema#string

Li-na Liang

http://www.w3.org/2001/XMLSchema#string

Li-na Liu

http://www.w3.org/2001/XMLSchema#string

Nan Wang

http://www.w3.org/2001/XMLSchema#string

Shu-ming Lu

http://www.w3.org/2001/XMLSchema#string

Yong Luan

http://www.w3.org/2001/XMLSchema#string

Zhu-qing Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3

Natural RNA circles function as efficient microRNA sponges

Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma.

Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies

Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway.

Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer.

Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression.

MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer.

MicroRNA-424 is down-regulated in hepatocellular carcinoma and suppresses cell migration and invasion through c-Myb.

miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215

P2888

1746-1596-9-135

P304

135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1746-1596-9-135

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263744083

http://www.w3.org/2001/XMLSchema#string

P6179

1030259766

http://www.w3.org/2001/XMLSchema#string

P698

24993656

http://www.w3.org/2001/XMLSchema#string

P921

P932

4226970

http://www.w3.org/2001/XMLSchema#string